Pharmaceutical Industry Business Outlook and Procurement Report H1 2016

Pharmaceutical Industry Business Outlook and Procurement Report H1 2016

Code: KAB-KG6230PR | Published: Apr-2016 | Pages: 44 | Kable
Price :
$1,950.00
USD

* Required Fields

$1,950.00

Details

The key priorities forecast in the business structure for global pharmaceutical industry executives in H1 2016 (April-September 2016) are new product development and improving operational efficiency. China, India, and Brazil are the leading emerging markets that are expected to offer the most opportunities for global pharmaceutical industry growth in H1 2016. Market uncertainty and rising competition are the immediate business concerns for global pharmaceutical industry executives. The gradual slowdown and restructuring of economic activity in China and tightening of the monetary policy in the US are creating a major concern for the pharmaceutical industry. Packaging equipment is expected to offer significant growth opportunities within the pharmaceutical industry in Asia-Pacific. Avoidance of counterfeiting and provision of longer shelf life are identified as the key drivers for pharmaceutical packaging companies to witness significant business opportunities within the Asia-Pacific region.

Key Findings
- The top three key priorities for H1 2016 (April-September 2016) as identified by respondents include new product development, improving operational efficiency, and expansion in current market

- Developed markets such as the US, the UK, and Japan are identified as important regions for growth over the next six months by pharmaceutical respondents

- New product development and IT infrastructure development will record a significant increase or notable increase in capital expenditure over the next six months

- Overall, 52% of executives operating in Europe assigned high preference for outright purchase of pharmaceutical equipment

- In Asia-Pacific, executives forecast packaging equipment and process equipment will offer significant revenue growth opportunities within the pharmaceutical industry

Synopsis
Kable's Pharmaceutical Industry Business Outlook and Procurement Report H1 2016 examines executives' opinion on business outlook and procurement activities over April-September 2016. It also highlights key business priorities, supplier price variations, changes in capital expenditure, and the key equipment and drug categories with the highest revenue contribution to the pharmaceutical industry. Additionally, it provides information categorized by region and company type.

What else does this report offer?

- Key business priorities: examines the pharmaceutical companies' important priorities for H1 (April-September) 2016

- Emerging and developed markets: provides information about key emerging and developed markets, which will offer most growth over H1 2016

- Change in MandA activity: analyzes pharmaceutical industry executives' opinion on changes in merger and acquisition activity globally

- Business concerns: identifies major business concerns that are likely to impact pharmaceutical companies

- Change in capital expenditure: tracks the expected change in capital expenditure both globally and regionally

- Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories

- Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2016 and expectations for 2017

- Equipment and drug categories: highlights the key equipment and drug categories with the highest revenue contribution to the pharmaceutical industry from 2016-2020

Reasons To Buy
- Highlights key business priorities thus helping pharmaceutical companies to realign business strategy

- Develop or adjust business expansion plans by using significant growth opportunities offered by key emerging and developed markets

- Make changes in procurement budget allocations through procurement budget projections anticipated by executives for April-September 2016

- Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016

- Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment

Table of Contents

Introduction

- Definitions
- Methodology and sample size
- Respondent profile

Global Business Outlook in H1 2016

- Strategic business priorities
- Emerging markets with significant growth potential
- Growth potential for developed markets
- Mergers and acquisition
- Leading business concerns
- Capital expenditure projections

Procurement Budget, Expenditure Outlook, and High-yield Categories

- Purchase preferences for pharmaceutical equipment
- Average expenditure per purchase
- Distribution of procurement budget between capital and operating expenditure
- Change in procurement budget expenditure
- Variation in pharmaceutical equipment budget from 2015-2016 to 2016-2017
- Highest revenue contributing regions for pharmaceutical equipment's market, 2016-2020
- Leading drug categories, 2016-2020
- Top most pharmaceutical equipment types, 2016-2020

Appendix

List of Figures


Figure 1: Organizations' Top Priorities - Overall, Apr 2016-Sep 2016
Figure 2: Organizations' Top Priorities - By Region, Apr 2016-Sep 2016
Figure 3: Organizations' Top Priorities - By Company Types, Apr 2016-Sep 2016
Figure 4: Emerging Market with Significant Growth Opportunities - Overall, Apr 2016-Sep 2016
Figure 5: Top Five Emerging Market with Significant Growth Opportunities - By Region, Apr 2016-Sep 2016
Figure 6: Top Five Emerging Market with Significant Growth Opportunities - By Company Types, Apr 2016-Sep 2016
Figure 7: Developing Markets with Prominent Growth Prospects - Overall, Apr 2016-Sep 2016
Figure 8: Top Five Developing Markets with Prominent Growth Prospects - By Region, Apr 2016-Sep 2016
Figure 9: Top Five Developing Markets with Prominent Growth Prospects - By Company Types, Apr 2016-Sep 2016
Figure 10: Change in Mergers and Acquisitions, Overall and Regional, Apr 2016-Sep 2016
Figure 11: Change in Mergers and Acquisitions, By Company Types, Apr 2016-Sep 2016
Figure 12: Major Concerns for Organizations - Overall, Apr 2016-Sep 2016
Figure 13: Major Concerns for Organizations - By Region, Apr 2016-Sep 2016
Figure 14: Major Concerns for Organizations - By Company Types, Apr 2016-Sep 2016
Figure 15: Change in Capital Expenditure in Key Areas - Overall, Apr 2016-Sep 2016
Figure 16: Change in Capital Expenditure in Key Areas - By Region, Apr 2016-Sep 2016
Figure 17: Change in Capital Expenditure in Key Areas - By Company Types, Apr 2016-Sep 2016
Figure 18: Purchase Preferences - By Region
Figure 19: Average Expenditure Per Purchase - Overall
Figure 20: Distribution of Procurement Budget - By Region
Figure 21: Change in Procurement Budget Expenditure - By Region
Figure 22: Change in Pharmaceutical Equipment Budget - By Region
Figure 23: Highest Revenue Contributing Regions for Pharmaceutical Equipment's Market, 2016 - Overall
Figure 24: Highest Revenue Contributing Regions for Pharmaceutical Equipment's Market, 2020 - Overall
Figure 25: Highest Revenue Contributing Regions for Pharmaceutical Equipment's Market, 2016-2020 - By Company Types
Figure 26: Leading Drug Categories By Region, 2016 - A - Overall
Figure 27: Leading Drug Categories By Region, 2016 - B - Overall
Figure 28: Leading Drug Categories By Region, 2020 - A - Overall
Figure 29: Leading Drug Categories By Region, 2020 - B - Overall
Figure 30: Top Most Pharmaceutical Equipment Types By Region, 2016 - A - Overall
Figure 31: Top Most Pharmaceutical Equipment Types By Region, 2016 - B - Overall
Figure 32: Top Most Pharmaceutical Equipment Types By Region, 2020 - A - Overall
Figure 33: Top Most Pharmaceutical Equipment Types By Region, 2020 - B - Overall
Sanofi S.A.
DiCE Molecules
Juno Therapeutics
WuXi AppTec
Mankind Pharma
Eagle Pharmaceuticals
Albany Molecular Research Inc. (AMRI)
Mylan
Meda Aktiebolag
Cipla
Exelan Pharmaceuticals Inc.
InvaGen Pharmaceuticals Inc
Johnson and Johnson
Tesaro Inc.
Aurobindo Pharma
Humanwell Healthcare Group and PuraCap Pharmaceutical

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
Kable